📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.
Catalyst Pharmaceuticals Inc
Catalyst Pharmaceuticals's GHG Emissions Data Preview
In 2024, Catalyst Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Catalyst Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Location-Based | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Verified Sources Behind Catalyst Pharmaceuticals’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Catalyst Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Insights into Catalyst Pharmaceuticals's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions ofCatalyst Pharmaceuticals amounted to54.6metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Catalyst Pharmaceuticals's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Catalyst Pharmaceuticals's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Catalyst Pharmaceuticals were 3.6 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a
What are Catalyst Pharmaceuticals's Scope 2 emissions?
In 2024, Catalyst Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 51 tCOâ‚‚e using the location-based method.a
What methodology does Catalyst Pharmaceuticals use for Scope 2 reporting?
In 2024, Catalyst Pharmaceuticals reported its Scope 2 emissions using the location-based method.a
Catalyst Pharmaceuticals's Scope 2 Emissions Over Time
- Total Scope 2 Location-Based
Insights into Catalyst Pharmaceuticals’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Catalyst Pharmaceuticals reported Scope 1 greenhouse gas (GHG) emissions of 3.6 tCOâ‚‚e and total revenues of USD 493 millions. This translates into an emissions intensity of 0.01 tCOâ‚‚e per millions USD.a
Catalyst Pharmaceuticals's Scope 1 Emissions Intensity Compared to Peers
How does Catalyst Pharmaceuticals's GHG emissions intensity compare to its peers?
In 2024, Catalyst Pharmaceuticals reported a Scope 1 emissions intensity of 0.01 tCOâ‚‚e per millions USD. Compared to the peer group median of 1.7, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
Where does Catalyst Pharmaceuticals rank on GHG emissions intensity within its industry?
In 2024, Catalyst Pharmaceuticals ranked 1 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a
This places Catalyst Pharmaceuticals among the top performers, with one of the lowest emissions intensities relative to peers.a